BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioInvest

Eppendorf to Invest EUR 40 Million in New Penang Manufacturing Facility

Eppendorf has signed an agreement for a new production site in Penang, Malaysia, marking the start of its planned greenfield manufacturing facility in Band...

July 30, 2026 | News

Navi Medical Secures A$6.8 Million to Commercialise Neonav® in US Paediatric Care

Melbourne- and Boston-based medical device company Navi Medical Technologies has closed a $A6.8 million capital raise to commercialise its breakthrough pae...

July 30, 2026 | News

Tikva Allocell Raises $8M Series A to Advance Off-the-Shelf CAR-T Therapy for Solid Tumours

Funding will support completion of IND-enabling activities and planned year-end IND submission for TAVST01, Tikva's lead off-the-shelf CAR-T candidate targ...

July 24, 2026 | News

NSG Bio and Chiesi Launch Initiative to Accelerate Respiratory and Neonatal Biotech Startups

The NSG Bio Tomorrow initiative aims at supporting emerging life sciences startups working on complex challenges in respiratory and neonatal care. Launche...

July 23, 2026 | News

Samsung Biologics Launches CHF 1.46B All-Cash Bid to Acquire PolyPeptide

Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury share...

July 21, 2026 | News

Merck Invests €25M to Expand BioReliance Testing Capabilities in Europe

• New 2,000-square-meter facility expands Merck’s global testing network with commercial drug substance and drug product release testing a...

July 17, 2026 | News

GEM Commits Up to $15.5M to Back Senhwa Biosciences’ Oncology Pipeline

GEM Global Yield LLC SCS ("GEM") has executed a Share Purchase Agreement (the "SPA") with the existing shareholders of Taiwan-listed Senhwa Biosciences Inc...

July 16, 2026 | News

Takeda Backs Indonesia's Plasma Ambitions with US$30 Million Investment to Build ASEAN's First Integrated Plasma Ecosystem

Ministry of Health of the Republic of Indonesia Grants Plasma Fractionation License, Enabling Takeda to Collect and Fractionate Plasma as Part of Multi...

July 14, 2026 | News

Australia's Second Plasma Fractionation Facility Targets Rising Import Dependence for Critical Plasma Medicines

AUSTRALIA SET TO IMPORT 70% OF VITAL PLASMA DERIVED MEDICINES BY 2030: NSW PRODUCTIVITY COMMISSION Australian biotech Aegros has completed A...

July 10, 2026 | News

Healome Therapeutics Raises £2 Million Seed Funding to Advance Eye-Drop Platform for Ocular Surface Diseases

Healome Therapeutics ("Healome"), a University of Birmingham spinout developing a proprietary eye-drop matrix technology for ocular surface diseases, has c...

July 09, 2026 | News

Vitex Inaugurates A$250M Wonderland Manufacturing Hub in Western Sydney

Vitex Pharmaceuticals Pty Ltd has officially inaugurated Wonderland, its new A$250 million pharmaceutical manufacturing facility at Eastern Creek in Wester...

July 06, 2026 | News

Icosagen Completes €45 Million Expansion to Deliver End-to-End Biologics Development and GMP Manufacturing at a Single Site

Estonia-based biotechnology company Icosagen has completed a major strategic expansion to strengthen its integrated biologics development and man...

July 01, 2026 | News

ChemT Biotechnology Raises US$5 Million to Advance AI-Powered Biomanufacturing Platform

The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavem...

June 23, 2026 | News

Rejuvenate Bio and Merck Animal Health Join Forces on Novel Animal Health Gene Therapy Programme

-- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, congratulates its portfolio company Rejuvenate...

June 15, 2026 | News

Stay Connected